Bessent, Powell warned bank CEOs about Anthropic model risks: Reuters
Treasury Secretary Scott Bessent and Federal Reserve Chair Jerome Powell convened an meeting with bank CEOs to warn of cyber risks posed by Anthropic’s AI.
Stefano Gabbana has stepped down as Dolce & Gabbana chairman but will keep a creative role
Stefano Gabbana has stepped down as chairman of the Italian fashion house that he co-founded with Domenico Dolce, but will continue in his creative role.
UBS downgrades ServiceNow, saying AI is a bigger threat than first believed
ServiceNow may be more vulnerable to disruption risks posed by AI than some analysts on the Street think, according to UBS.
Stocks making the biggest moves premarket: Lumentum, ServiceNow, Sandisk & more
These are the stocks posting the largest moves premarket.
BlackRock rips page from hedge fund playbook, applies it to exchange-traded funds
BlackRock’s Jeffrey Rosenberg has a leading role in the firm’s liquid alt ETFs — which use a long-short strategy in ETF wrappers.
Nike shares are still not cheap after 30% drawdown this year, says Piper Sandler
Nike could struggle with sales as the athleisure market becomes more crowded and demand for sports-focused loungewear moves past its peak, per Piper Sandler.
How ‘married filing separately’ status could affect Trump tax breaks this season
The married filing separately status could affect eligibility for President Donald Trump’s tax breaks this season. Here’s what filers need to know.
China’s Xi invokes ‘threat’ of Taiwan independence in first cross-strait opposition talks in a decade
Xi Jinping hosted Taiwan’s main opposition leader in Beijing for the first time in a decade, ahead of a high-stakes meeting with Trump in May and Taiwan’s presidential election in 2028.
TSMC posts 35% jump in revenue to new record high as AI chip demand stays strong
TSMC is benefiting from sustained demand for advanced semiconductors from its key customers like Apple and Nvidia.
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.